Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Ganaxolone for Patients with Refractory Status Epilepticus
BelgiumStudy Comparing Patritumab Deruxtecan and Platinum-based Chemotherapy for Patients with Advanced EGFR-mutated Non-small Cell Lung Cancer After EGFR Therapy Failure
BelgiumStudy on the Safety of Avacincaptad Pegol for Patients with Geographic Atrophy Who Completed a Previous Study
BelgiumStudy on Midostaurin and Decitabine for Adults with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome Who Are Unfit for Intensive Treatment
BelgiumStudy of Tarlatamab Treatment for Patients with Small Cell Lung Cancer Who Have Not Responded to Two or More Previous Treatments
BelgiumStudy of Avapritinib for Patients with Indolent Systemic Mastocytosis Not Adequately Managed by Standard Therapy
BelgiumStudy of MCLA-129 with Chemotherapy and Osimertinib for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors
BelgiumStudy of OSE2101 vaccine alone or with pembrolizumab as maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer after chemotherapy
BelgiumStudy on Efgartigimod for Patients with Antibody-Mediated Rejection after Kidney Transplant
BelgiumStudy on Cabozantinib, Nivolumab, and Ipilimumab for Patients with Advanced or Metastatic Kidney Cancer Who Have Not Received Prior Treatment
BelgiumStudy on Selinexor as Maintenance Therapy for Patients with Advanced or Recurrent Endometrial Cancer After Chemotherapy
BelgiumStudy Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
